These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 28225679)
21. [Sample and titer of pharmaceutical forms]. Setnikar I Boll Chim Farm; 1968 Mar; 107(3):168-72. PubMed ID: 5730324 [No Abstract] [Full Text] [Related]
22. WHO must defend patients' interests, not industry. Cawthorne P; Ford N; Limpananont J; Tienudom N; Purahong W Lancet; 2007 Mar; 369(9566):974-5. PubMed ID: 17382809 [No Abstract] [Full Text] [Related]
23. Regulatory and Economic Considerations of Retinal Drugs. Shah AR; Williams GA Dev Ophthalmol; 2016; 55():376-80. PubMed ID: 26502165 [TBL] [Abstract][Full Text] [Related]
24. Pharmaceuticals and medical devices: business practices. Steiner DJ Issue Brief Health Policy Track Serv; 2013 Dec; ():1-36. PubMed ID: 24482889 [No Abstract] [Full Text] [Related]
25. Pharmaceuticals and medical devices: cost savings. ; Steiner DJ Issue Brief Health Policy Track Serv; 2012 Jan; ():1-37. PubMed ID: 22403843 [No Abstract] [Full Text] [Related]
26. A Wish List for Drug Development in Pediatrics. Meyers R J Pharm Sci; 2020 Feb; 109(2):939-943. PubMed ID: 31676269 [TBL] [Abstract][Full Text] [Related]
27. Fake pharmaceuticals: how they and relevant legislation or lack thereof contribute to consistently high and increasing drug prices. Moken MC Am J Law Med; 2003; 29(4):525-42. PubMed ID: 15119247 [No Abstract] [Full Text] [Related]
28. [Precautions for use of pharmaceuticals]. Oniyama Y; Fushimi T Nihon Rinsho; 2007 Oct; 65 Suppl 8():25-8. PubMed ID: 18074512 [No Abstract] [Full Text] [Related]
29. Pediatric cancer chemotherapy formulations remain elusive. Traynor K Am J Health Syst Pharm; 2010 Feb; 67(3):170-1. PubMed ID: 20101052 [No Abstract] [Full Text] [Related]
30. Pharmaceuticals and medical devices: cost savings. End-of-year issue brief. Health Policy Tracking Service, A Service of Thomson Reuters/West Issue Brief Health Policy Track Serv; 2011 Jan; ():1-21. PubMed ID: 21374837 [No Abstract] [Full Text] [Related]
31. International initiatives on extemporaneous dispensing. Nunn A; Aindow A; Woods D Int J Pharm; 2012 Oct; 435(2):135-7. PubMed ID: 22883697 [No Abstract] [Full Text] [Related]
32. [Problems posed by the adjusting of a dosage form of a drug for children]. Bernheim C Therapie; 1989; 44(2):145-50. PubMed ID: 2756521 [TBL] [Abstract][Full Text] [Related]
33. [Drug dosage form and action]. Zathurecký L Med Klin; 1974 Apr; 69(16):667-70. PubMed ID: 4837397 [No Abstract] [Full Text] [Related]
36. Regulatory aspects of devices. Wachtel H Int J Pharm; 2012 Oct; 435(2):142-4. PubMed ID: 22883700 [No Abstract] [Full Text] [Related]
37. New rules for US drug reimbursement. Bouchie A Nat Biotechnol; 2003 Oct; 21(10):1119-20. PubMed ID: 14520382 [No Abstract] [Full Text] [Related]
38. Considerations in the use of medications in the pediatric patient. Caselli MA J Am Podiatry Assoc; 1981 Feb; 71(2):54-9. PubMed ID: 7204849 [No Abstract] [Full Text] [Related]
39. [Drug manufacturer on the savings package of Ulla Schmidt. "Grip in the moth box of planned economics"]. Schmidt K MMW Fortschr Med; 2001 Nov; 143(44):52. PubMed ID: 11732398 [No Abstract] [Full Text] [Related]